Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy

Memorial Sloan Kettering Cancer Center (MSK)

Status: Active, not recruiting

Conditions: Stage III Ovarian Cancer; Primary Peritoneal Carcinoma; Fallopian Tube Cancer; Stage IV Ovarian Cancer; Ovarian Cancer; Fallopian Tube Carcinoma

Treatments: Other: Prehabilitation

Study type: Interventional

Funder types: Other

Identifiers

NCT04204811

19-347

Details and patient eligibility

About

The purpose of this study is evaluate whether a prehabilitation program is feasible and useful for women with advanced ovarian cancer receiving chemotherapy in preparation for debulking surgery.

Enrollment: 22 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects must be diagnosed with Stage III or Stage IV ovarian carcinoma (which includes primary peritoneal carcinoma or fallopian rube carcinoma)
• All subjects must be enrolled within 90 days of diagnosis
• No prior treatment for ovarian carcinoma
• All subjects have agreed to a treatment plan of neoadjuvant chemotherapy and subsequent planned interval debulking surgery with an MSKCC surgeon
• Participants must be initiating treatment at Gynecologic Medical Oncology clinics at MSKCC Manhattan
• Proficiency in English in the determination of the investigators of by patient self-report

Exclusion criteria

• Patient under age 18
• Prior treatment for ovarian cancer
• Second opinion visit only
• Immediate surgery plan without neoadjuvant treatment
• No intended surgical plan
• Chemotherapy administration exclusively planned at MSKCC regional site
• Patient unwilling to sign consent

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

22 participants in 1 patient group

Participants with Ovarian Cancer

Experimental group

Description:

Participants are diagnosed with Stage III or Stage IV ovarian carcinoma (which includes primary peritoneal carcinoma or fallopian tube carcinoma)

Treatment:

Other: Prehabilitation